Prostaglandin I2 Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension

Am J Respir Crit Care Med. 2023 Sep 15;208(6):737-739. doi: 10.1164/rccm.202304-0716LE.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Epoprostenol / therapeutic use
  • Familial Primary Pulmonary Hypertension
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • Pulmonary Arterial Hypertension* / drug therapy
  • T-Lymphocytes, Regulatory

Substances

  • Epoprostenol